文献速递外周动脉疾病

负压伤口治疗用于腹股沟切口下腔血管重建的多中心随机试验

A multicenter, prospective randomized trial of negative pressure wound therapy for infrainguinal revascularization with a groin incision.
PubMed 文献 · J Vasc Surg · 2021-02-04

BACKGROUND: Wound complications after open infrainguinal revascularization are a frequent cause of patient morbidity, resulting in increased healthcare costs.…

要点

  • ciNPT与标准纱布在30天腹股沟伤口并发症复合终点无差异。
  • 对照组感染率低于其他研究,提示护理流程可能影响结果。

核心结论

  • 在多中心随机试验中,下腔血管重建患者使用ciNPT与标准纱布敷料相比,30天腹股沟伤口并发症无差异。

研究设计与样本

  • 多中心前瞻性随机对照试验,纳入242例在五家学术医疗中心接受下腔旁路术(n=124)或股动脉内膜切除术(n=118)的患者,随机分为ciNPT组(n=118)和标准纱布组(n=124)。

临床怎么用

  • 对于下腔血管重建的腹股沟切口,ciNPT并未显示优于标准纱布敷料,不应常规用于所有患者。
  • 对照组感染率较低提示优化围手术期护理流程可能比常规使用ciNPT更重要。

局限性

  • 研究未针对亚组分层进行效能设计,无法确定高危亚组是否可能获益。
  • 对照组手术部位感染率低于其他研究,可能影响结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wound complications after open infrainguinal revascularization are a frequent cause of patient morbidity, resulting in increased healthcare costs. The purpose of the present study was to assess the effects of closed incision negative pressure therapy (ciNPT) on groin wound complications after infrainguinal bypass and femoral endarterectomy. METHODS: A total of 242 patients who had undergone infrainguinal bypass (n = 124) or femoral endarterectomy (n = 118) at five academic medical centers in New England from April 2015 to August 2019 were randomized to ciNPT (PREVENA; 3M KCI, St Paul, Minn; n = 118) or standard gauze (n = 124). The primary outcome measure was a composite endpoint of groin wound complications, including surgical site infections (SSIs), major noninfectious wound complications, or graft infections within 30 days after surgery. The secondary outcome measures included 30-day SSIs, 30-day noninfectious wound complications, readmission for wound complications, significant adverse events, and health-related quality of life using the EuroQoL 5D-3L survey. RESULTS: The ciNPT and control groups had similar demographics (age, 67 vs 67 years, P = .98; male gender, 71% vs 70%, P = .86; white race, 93% vs 93%, P = .97), comorbidities (previous or current smoking, 93% vs 94%, P = .46; diabetes, 41% vs 48%, P = .20; renal insufficiency, 4% vs 7%, P = .31), and operative characteristics, including procedure type, autogenous conduit, and operative time. No differences were found in the primary composite outcome at 30 days between the two groups (ciNPT vs control: 31% vs 28%; P = .55). The incidence of SSI at 30 days was similar between the two groups (ciNPT vs control: 11% vs 12%; P = .58). Infectious (13.9% vs 12.6%; P = .77) and noninfectious (20.9% vs 17.6%; P = .53) wound complications at 30 days were also similar for the ciNPT and control groups. Wound complications requiring readmission also similar between the two groups (ciNPT vs control: 9% vs 7%; P = .54). The significant adverse event rates were not different between the two groups (ciNPT vs control: 13% vs 16%; P = .53). The mean length of the initial hospitalization was the same for the ciNPT and control groups (5.2 vs 5.7 days; P = .63). The overall health-related quality of life was similar at baseline and at 14 and 30 days postoperatively for the two groups. Although not powered for stratification, we found no differences among the subgroups in gender, obesity, diabetes, smoking, claudication, chronic limb threatening ischemia, bypass, or endarterectomy. On multivariable analysis, no differences were found in wound complications at 30 days for the ciNPT vs gauze groups (odds ratio, 1.4; 95% confidence interval, 0.8-2.6; P = .234). CONCLUSIONS: In contrast to other randomized studies, our multicenter trial of infrainguinal revascularization found no differences in the 30-day groin wound complications for patients treated with ciNPT vs standard gauze dressings. However, the SSI rate was lower in the control group than reported in other studies, suggesting other practice patterns and processes of care might have reduced the rate of groin infections. Further study might identify the subsets of high-risk patients that could benefit from ciNPT.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bertges DJ, Smith L, Scully RE, et al. A multicenter, prospective randomized trial of negative pressure wound therapy for infrainguinal revascularization with a groin incision. J Vasc Surg. 2021. PMID: 33548422. doi:10.1016/j.jvs.2020.12.100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。